Microfluidics & lab-on-chip research lab

Microfluidics & lab-on-chip research lab is a world-leading provider of cutting-edge research, training, consultancy, and contract R&D services specializing in microfluidics and lab-on-chip technologies. Recognized for innovation and excellence, Microfluidics & lab-on-chip research lab offers comprehensive solutions for nanomedicines, drug discovery, development, and diagnostics. The primary address is School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, GB.

Microfluidics & lab-on-chip research lab excels in the manufacturing of polymer-based (e.g., PLGA), lipid-based (e.g., liposomes, Solid lipid nanoparticles, niosomes, exosomes), hybrid, supramolecular assembly, metal-based (e.g., Au), and Nanocrystalline Nanomedicines using microfluidics. These advanced methods are compared with traditional formulation techniques, ensuring the highest standards of quality and efficiency. Microfluidics & lab-on-chip research lab is also at the forefront of developing nanoparticles for imaging, treatment, and targeted drug delivery, including surface modification for cancer treatment.

With a commitment to advancing scientific knowledge, Microfluidics & lab-on-chip research lab is dedicated to pushing the boundaries of microfluidic technology. Microfluidics & lab-on-chip research lab's in-house capabilities include the fabrication of microfluidic chips via 3D Printing & Bioprinting, and injection molding. The lab conducts thorough studies encompassing conceptualization, nanomedicine formulation, chip manufacturing, advanced physicochemical characterization, computational modelling, and in vivo, ex vivo, and in vitro evaluations. We invite the management team to create a customized and exclusive company showcase and product listing on our platform to further amplify Microfluidics & lab-on-chip research lab's reach and impact.